Catalyst Wire Dossier Catalyst Wire Dossier

Hypoallergenic derivatives of Bet v 1

· Medical University of Vienna
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hypoallergenic derivatives of Bet v 1, covering 2011-05-16 to 2011-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1 [Phase 1]

See pricing